BUTABARB Drug Patent Profile
Which patents cover Butabarb, and what generic alternatives are available?
Butabarb is a drug marketed by Alpharma Us Pharms, Bundy, Wockhardt, Sandoz, Solvay, Teva, Watson Labs, and Whiteworth Town Plsn. and is included in seventeen NDAs.
The generic ingredient in BUTABARB is butabarbital sodium. There is one drug master file entry for this compound. Additional details are available on the butabarbital sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BUTABARB?
- What are the global sales for BUTABARB?
- What is Average Wholesale Price for BUTABARB?
Summary for BUTABARB
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 17 |
| Raw Ingredient (Bulk) Api Vendors: | 6 |
| Patent Applications: | 1,217 |
| DailyMed Link: | BUTABARB at DailyMed |
US Patents and Regulatory Information for BUTABARB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpharma Us Pharms | BUTABARB | butabarbital sodium | ELIXIR;ORAL | 085873-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz | BUTABARBITAL SODIUM | butabarbital sodium | TABLET;ORAL | 085934-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz | BUTABARBITAL SODIUM | butabarbital sodium | TABLET;ORAL | 084292-003 | Feb 9, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | BUTABARBITAL SODIUM | butabarbital sodium | TABLET;ORAL | 088632-001 | May 18, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Solvay | BUTABARBITAL SODIUM | butabarbital sodium | TABLET;ORAL | 083606-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Whiteworth Town Plsn | BUTABARBITAL SODIUM | butabarbital sodium | TABLET;ORAL | 083325-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
